MOH — authorised 27 February 2008
- Marketing authorisation holder: REGENERON PHARMACEUTICALS
- Status: likely_approved
MOH authorised Arcalyst on 27 February 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 27 February 2008.
REGENERON PHARMACEUTICALS holds the UAE marketing authorisation.